Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2020-08-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
전환가액의조정(제16회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (제16회차) issued by Lumimicro. It details the calculation method, the change in conversion price, and the impact on the number of convertible shares. This type of disclosure relates to capital structure changes and financing terms, which falls under the 'Capital/Financing Update' category.
2020-08-31 Korean
전환가액의조정(제18회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Lumimicro regarding the adjustment of the conversion price for its 18th series convertible bonds. It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2020-08-31 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Lumimicro Co., Ltd., covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which are characteristic of an interim financial report. It is not a mere announcement or certification, but the full report itself. H1 2020
2020-08-14 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Lumi Micro) regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It details the date, location, and agenda items (such as company name change and director appointment) for an Extraordinary General Meeting. This type of document is a formal notice to shareholders regarding upcoming voting procedures and meeting logistics, which falls under the Proxy Solicitation & Information Statement category.
2020-08-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by an investment advisory firm (한국채권투자자문) in a specific company (루미마이크로). This falls under the category of Major Shareholding Notification as it tracks significant ownership thresholds and changes.
2020-08-03 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Lumi Micro'. It outlines the date, time, location, and agenda items (such as changing the company name). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon. Given the provided categories, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting.
2020-08-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.